{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:13:49Z","timestamp":1786990429311,"version":"build-2736575974"},"reference-count":7,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.ijcard.2014.03.111","type":"journal-article","created":{"date-parts":[[2014,3,22]],"date-time":"2014-03-22T01:08:38Z","timestamp":1395450518000},"page":"e45-e46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Reversible dilated cardiomyopathy associated with long-term anagrelide therapy in a patient with chronic myeloproliferative disease: A serial 2-dimensional speckle tracking echocardiographic study"],"prefix":"10.1016","volume":"173","author":[{"given":"Sun Hwa","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Sik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2014.03.111_bb0005","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2165\/00003495-199447050-00007","article-title":"Anagrelide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of thrombocythaemia","volume":"47","author":"Spencer","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.ijcard.2014.03.111_bb0010","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1592\/phco.20.15.1224.34591","article-title":"Anagrelide-induced cardiomyopathy","volume":"20","author":"James","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijcard.2014.03.111_bb0015","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.leukres.2011.06.030","article-title":"Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia","volume":"35","author":"Gugliotta","year":"2011","journal-title":"Leuk Res"},{"key":"10.1016\/j.ijcard.2014.03.111_bb0020","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7326\/0003-4819-143-4-200508160-00020","article-title":"High-output heart failure associated with anagrelide therapy for essential thrombocytosis","volume":"143","author":"Engel","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijcard.2014.03.111_bb0025","first-page":"1394","article-title":"Anagrelide-associated cardiomyopathy in polycythemia vera and essential thrombocythemia","volume":"89","author":"Jurgens","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.ijcard.2014.03.111_bb0030","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/echo.12079","article-title":"Two- and three-dimensional speckle tracking echocardiography: clinical applications and future directions","volume":"30","author":"Biswas","year":"2013","journal-title":"Echocardiography"},{"key":"10.1016\/j.ijcard.2014.03.111_bb0035","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.jacc.2010.11.063","volume":"57","author":"Fallah-Rad","year":"2011","journal-title":"J Am Coll Cardiol"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314005476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314005476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T16:51:56Z","timestamp":1538758316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527314005476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0167527314005476"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.03.111","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversible dilated cardiomyopathy associated with long-term anagrelide therapy in a patient with chronic myeloproliferative disease: A serial 2-dimensional speckle tracking echocardiographic study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.03.111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}